Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Perioperative Mood in Cardiac Valve Surgery
NCT06608030Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Sep 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine in anxiety disorder and major depressive disorder (MDD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Perioperative anxiety and depression. Started Sep 2024; status: completed.
02
Drugs
esketamine
03
Conditions
anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06608030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608030.